UBS Group’s Newborn Acquisition Corp Warrant NVVEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,410
Closed -$25 10975
2025
Q3
$25 Buy
+1,410
New +$31 ﹤0.01% 10110
2025
Q2
Sell
-2,616
Closed -$44 10665
2025
Q1
$44 Buy
+2,616
New +$66 ﹤0.01% 10026
2023
Q1
Sell
-19,431
Closed -$1.17K 10133
2022
Q4
$1.17K Buy
19,431
+11,953
+160% +$841 ﹤0.01% 9934
2022
Q3
$1K Buy
7,478
+1,999
+36% +$550 ﹤0.01% 9996
2022
Q2
$2K Buy
5,479
+4,563
+498% +$3.3K ﹤0.01% 9594
2022
Q1
$1K Sell
916
-1,791
-66% -$1.67K ﹤0.01% 9895
2021
Q4
$6K Sell
2,707
-3,678
-58% -$8.27K ﹤0.01% 9280
2021
Q3
$9K Buy
+6,385
New +$10.1K ﹤0.01% 8102
2021
Q2
Sell
-6,362
Closed -$12K 9669
2021
Q1
$12K Buy
6,362
+3,809
+149% +$10K ﹤0.01% 7801
2020
Q4
$8K Buy
2,553
+616
+32% +$832 ﹤0.01% 7630
2020
Q3
$1K Sell
1,937
-513
-21% -$89 ﹤0.01% 7816
2020
Q2
$0 Buy
+2,450
New +$234 ﹤0.01% 8234

Other funds holding NVVEW

UBS Group's NVVEW Position: Q4 2025 in Review

UBS Group sold out of Newborn Acquisition Corp Warrant (NVVEW) in Q4 2025, closing a stake of 1,410 shares — an estimated $25 sold.

UBS Group first reported a position in NVVEW in Q2 2020 and held it in 12 quarters. The position peaked at $12K in Q1 2021. 4 funds tracked by Wall St. Rank hold NVVEW as of Q4 2025.

  • UBS Group reported no remaining Newborn Acquisition Corp Warrant position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 1,410 Newborn Acquisition Corp Warrant shares in Q4 2025, an estimated $25.
  • UBS Group first reported a position in Newborn Acquisition Corp Warrant in Q2 2020 and held it in 12 quarters.
  • UBS Group's Newborn Acquisition Corp Warrant position peaked at $12K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Newborn Acquisition Corp Warrant as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.